| Mr Michael A D'amico, MD | |
|
111 Colchester Ave, Burlington, VT 05401-1473 | |
| (802) 847-8200 | |
| (802) 847-8742 |
| Full Name | Mr Michael A D'amico |
|---|---|
| Gender | Male |
| Speciality | Pediatrics - Pediatric Gastroenterology |
| Location | 111 Colchester Ave, Burlington, Vermont |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1790719326 | NPI | - | NPPES |
| 1011059 | Medicaid | VT | |
| 01958185 | Medicaid | NY |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2080P0206X | Pediatrics - Pediatric Gastroenterology | 420010871 (Vermont) | Primary |
| Entity Name | University Of Vermont Medical Center Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1659309615 PECOS PAC ID: 3779491071 Enrollment ID: O20040406001047 |
News Archive
Researchers in the United States have warned that as of July 15th this year (2021), the level of population immunity against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – the agent that causes coronavirus disease 2019 (COVID-19) – may still have been insufficient to contain infection outbreaks and safely return to pre-pandemic social behavior.
A review article has been published in the journal Current Pharmaceutical Design which provides an overview of therecent literature discussing the different clinical forms of heart disease resulting from virus infections including the prognosis, and current therapies.
Today, the U.S. Food and Drug Administration approved a new indication for Myrbetriq (mirabegron extended-release tablets) and Myrbetriq Granules (mirabegron for extended-release oral suspension) to treat neurogenic detrusor overactivity (NDO), a bladder dysfunction related to neurological impairment, in children ages three years and older.
Administration officials sent letters to college and university presidents and student body leaders reminding them to communicate to students about how, because of changes resulting from the health overhaul, they can remain on a parent's plan until age 26. In other health reform news, President Obama says that he is flexible on health reform, and the AP reports on how the absence of one Supreme Court justice on certain legal questions has been "no big deal."
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mr Michael A D'amico, MD 111 Colchester Ave, Burlington, VT 05401-1473 Ph: (802) 847-4488 | Mr Michael A D'amico, MD 111 Colchester Ave, Burlington, VT 05401-1473 Ph: (802) 847-8200 |
News Archive
Researchers in the United States have warned that as of July 15th this year (2021), the level of population immunity against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – the agent that causes coronavirus disease 2019 (COVID-19) – may still have been insufficient to contain infection outbreaks and safely return to pre-pandemic social behavior.
A review article has been published in the journal Current Pharmaceutical Design which provides an overview of therecent literature discussing the different clinical forms of heart disease resulting from virus infections including the prognosis, and current therapies.
Today, the U.S. Food and Drug Administration approved a new indication for Myrbetriq (mirabegron extended-release tablets) and Myrbetriq Granules (mirabegron for extended-release oral suspension) to treat neurogenic detrusor overactivity (NDO), a bladder dysfunction related to neurological impairment, in children ages three years and older.
Administration officials sent letters to college and university presidents and student body leaders reminding them to communicate to students about how, because of changes resulting from the health overhaul, they can remain on a parent's plan until age 26. In other health reform news, President Obama says that he is flexible on health reform, and the AP reports on how the absence of one Supreme Court justice on certain legal questions has been "no big deal."
› Verified 9 days ago
Anisha Rimal, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 111 Colchester Ave, Burlington, VT 05401 Phone: 802-847-0000 | |
Dr. William Raszka, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 111 Colchester Ave, Burlington, VT 05401 Phone: 802-847-8200 Fax: 802-847-8742 | |
Dr. Valerie J. Riss, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 111 Colchester Ave., C/o Uvm Medical Center, Children's/pedi-hospitalists, Burlington, VT 05401 Phone: 802-847-2700 | |
Dr. Nancy A Drucker, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 111 Colchester Ave, Burlington, VT 05401 Phone: 802-847-8200 Fax: 802-847-8742 | |
Dr. Nilgun Tapucu Zimakas, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 1 S Prospect St, Burlington, VT 05401 Phone: 802-847-4696 Fax: 902-847-4612 | |
Dr. Joseph Francis Hagan Jr., M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 128 Lakeside Ave, Suite 115, Burlington, VT 05401 Phone: 802-860-1928 | |
Dr. Elizabeth Duncan Ulano, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 111 Colchester Ave., Uvm Medical Center, Children's/picu, Burlington, VT 05401 Phone: 802-847-2304 Fax: 802-847-0258 |